Comparison of the efficacy between paclitaxel/carboplatin and doxorubicin/cisplatin for concurrent chemoradiation in intermediate- or high-risk endometrioid endometrial cancer: A single institution experience

Journal of Obstetrics and Gynaecology Research

Volumn 36, Issue 3, 2010, Pages 598-604

  Kim, Hee Seung ^a   Kim, Jae Weon ^a   Wu, Hong Gyun ^a   Chung, Hyun Hoon ^a   Park, Noh Hyun ^a   Song, Yong Sang ^a,b   Kang, Soon Beom ^a   Lee, Hyo Pyo ^c  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c Konkuk University Hospital   (South Korea)

Author keywords

Carboplatin; Cisplatin; Doxorubicin; Endometrioid endometrial cancer; Paclitaxel

Indexed keywords

CARBOPLATIN; CARBOPLATIN PLUS PACLITAXEL; CISPLATIN; CISPLATIN PLUS DOXORUBICIN; DOXORUBICIN; PACLITAXEL; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT;

ADULT; AGED; ANEMIA; ARTICLE; BLEEDING; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONSTIPATION; CONTROLLED STUDY; DRUG EFFICACY; ENDOMETRIOID ENDOMETRIAL CANCER; ENDOMETRIUM CANCER; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HAZARD RATIO; HEMATURIA; HIGH RISK PATIENT; HUMAN; ILEUS; LEUKOPENIA; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUTROPENIA; OVERALL SURVIVAL; PROCTITIS; PROGNOSIS; PROGRESSION FREE SURVIVAL; RECTOVAGINAL FISTULA; RETROSPECTIVE STUDY; THROMBOCYTOPENIA; ADJUVANT THERAPY; CARCINOMA, ENDOMETRIOID; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FACTUAL DATABASE; MIDDLE AGED; NONPARAMETRIC TEST; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, ENDOMETRIOID; CISPLATIN; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; DOXORUBICIN; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PACLITAXEL; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 77953330295     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2010.01223.x     Document Type: Article

References (27)

1. Lee HP. Annual report of gynecologic cancer regisrty program in Korea: 1191-2004. Korean J Obstet Gynecol 2008 51 : 1411 1420.
2. Creasman WT, Odicino F, Maisonneuve P et al. Carcinoma of the corpus uteri. FIGO 6th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 2006 95 : S105 S143.
3. Kim K, Ryu SY. Major clinical research advances in gynecologic cancer 2009. J Gynecol Oncol 2009 20 : 203 209.
4. Kuwabara Y, Susumu N, Banno K et al. Clinical characteristics of prognostic factors in poorly differentiated (G3) endometrioid adenocarcinoma in Japan. Jpn J Clin Oncol 2005 35 : 23 27.
5. Creutzberg CL, Van Putten WL, Koper PC et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: Multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 2000 355 : 1404 1411.
6. Aalders J, Abeler V, Kolstad P, Onsrud M. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: Clinical and histopathologic study of 540 patients. Obstet Gynecol 1980 56 : 419 427.
7. Keys HM, Roberts JA, Brunetto VL et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: A Gynecologic Oncology Group study. Gynecol Oncol 2004 92 : 744 751.
8. Greven K, Winter K, Underhill K, Fontenesci J, Cooper J, Burke T. Final analysis of RTOG 9708: Adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer. Gynecol Oncol 2006 103 : 155 159.
9. RTOG 9905/GOG 0194. Comparison of radiation therapy with or without combination chemotherapy following surgery in treating patients with stage I or stage II endometrial cancer. 2008 Cited 12 November 2008.] Available from URL. http://clinicaltrials.gov/ct2/show/NCT00006027?term=RTOG+9905&rank=1.
10. PORTEC-3. Chemotherapy and radiation therapy compared with radiation therapy alone in treating patients with high-risk stage I, stage II, or stage III endometrial cancer. 2008 Cited 12 November 2008.] Available from URL. http://clinicaltrials.gov/ct2/show/NCT00411138?term=PORTEC-3&rank=1.
11. Gadducci A, Cosio S, Genazzani AR. Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: Hormonal therapy, chemotherapy and molecularly targeted therapies. Crit Rev Oncol Hematol 2006 58 : 242 256.
12. Akram T, Maseelall P, Fanning J. Carboplatin and paclitaxel for the treatment of advanced or recurrent endometrial cancer. Am J Obstet Gynecol 2005 192 : 1365 1367.
13. Hidaka T, Nakamura T, Shima T, Yuki H, Saito S. Paclitaxel/carboplatin versus cyclophosphamide/adriamycin/cisplatin as postoperative adjuvant chemotherapy for advanced endometrial adenocarcinoma. J Obstet Gynaecol Res 2006 32 : 330 337.
14. Lupe K, Kwon J, D'Souza D et al. Adjuvant paclitaxel and carboplatin chemotherapy with involved field radiation in advanced endometrial cancer: A sequential approach. Int J Radiat Oncol Biol Phys 2007 67 : 110 116.
15. Oken MM, Creech RH, Tormey DC et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982 5 : 649 655.
16. Thigpen JT, Brady MF, Homesley HD et al. Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: A gynecologic oncology group study. J Clin Oncol 2004 22 : 3902 3908.
17. Aapro MS, Van Wijk FH, Bolis G et al. Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: Definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group. Ann Oncol 2003 14 : 441 448.
18. Hogberg T, Rosenberg P, Kristensen G et al. A randomized phase III study on adjuvant treatment with radiation (RT) with or without chemotherapy (CT) in early stage high-risk endometrial cancer (NSGO-EC-9501/EORTC 55991). J Clin Oncol 2007 25 abstract 5503 GF, Brunetto VL, Cella D et al. Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: A Gynecologic Oncology Group Study. J Clin Oncol 2004 22 : 2159 2166.
19. Hogberg T. Adjuvant chemotherapy in endometrial carcinoma: Overview of randomised trials. Clin Oncol (R Coll Radiol) 2008 20 : 463 469.
20. Sorbe B, Andersson H, Boman K, Rosenberg P, Kalling M. Treatment of primary advanced and recurrent endometrial carcinoma with a combination of carboplatin and paclitaxel-long-term follow-up. Int J Gynecol Cancer 2008 18 : 803 808.
21. Humber CE, Tierney JF, Symons RP et al. Chemotherapy for advanced, recurrent or metastatic endometrial cancer: A systematic review of Cochrane collaboration. Ann Oncol 2007 18 : 409 420.
22. Sovak MA, Dupont J, Hensley ML et al. Paclitaxel and carboplatin in the treatment of advanced or recurrent endometrial cancer: A large retrospective study. Int J Gynecol Cancer 2007 17 : 197 203.
23. Mangili G, De Marzi P, Beatrice S et al. Paclitaxel and concomitant radiotherapy in high-risk endometrial cancer patients: Preliminary findings. BMC Cancer 2006 6 : 198.
24. Michener CM, Peterson G, Kulp B, Webster KD, Markman M. Carboplatin plus paclitaxel in the treatment of advanced or recurrent endometrial carcinoma. J Cancer Res Clin Oncol 2005 131 : 581 584.
25. GOG 209. Phase III randomized study of doxorubicin, cisplatin, paclitaxel, and filgrastim (G-CSF) versus carboplatin and paclitaxel in patients with stage III or IV or recurrent endometrial cancer. 2008 Cited 12 November 2008.] Available from URL. http://www.cancer.gov/search/ViewClinicalTrials.aspx? cdrid=305940&version=patient&protocolsearchid=2411014.
26. Foda I, Sharawy I, Mostafa E, Margergis M, Hussein T. Concurrent cisplatin/radiation followed by adjuvant cisplatin/paclitaxel in treatment of patients with stage IB grade 3, IC and IIA endometrial carcinoma. J Egypt Natl Canc Inst 2007 19 : 163 169.
27. Soper JT, Reisinger SA, Ashbury R, Jones E, Clarke-Pearson DL. Feasibility study of concurrent weekly cisplatin and whole abdominopelvic irradiation followed by doxorubicin/cisplatin chemotherapy for advanced stage endometrial carcinoma: A Gynecologic Oncology Group trial. Gynecol Oncol 2004 95 : 95 100.